Legal status · United States
Is Young Plasma Infusion legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Young Plasma Infusion is an approved medicine in the United States, classified as "Licensed blood component; infusion for ageing is an unapproved use". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Young Plasma Infusion in the United States at a glance
| Classification | Licensed blood component; infusion for ageing is an unapproved use |
|---|---|
| Note | FDA consumer statement of 19 February 2019 advises caution about establishments selling young donor plasma infusions. |
| FDA approval status | Plasma is a licensed blood component with defined clinical indications in coagulation and plasma exchange. Infusion for ageing, memory loss or neurodegeneration is not an approved use. FDA published a consumer warning about clinics selling it on 19 February 2019. |
| Human studies cited | 3 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Young Plasma Infusion profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Young Plasma Infusion for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Young Plasma Infusion is
Plasma from donors aged 18 to 30 infused into older people. The one randomised trial enrolled 18 patients with Alzheimer disease and was powered for safety, not effect. FDA published a consumer warning about clinics selling it in February 2019.
The idea comes from heterochronic parabiosis, an experiment in which the circulatory systems of a young and an old mouse are joined. A 2011 Nature paper showed that blood-borne factors in an old systemic environment suppress neurogenesis and impair learning and memory in young mice, and that the reverse direction produces the opposite effect.
Mechanism: Not established in humans. In mice, plasma from young animals carries factors including TIMP2, platelet factor 4, Gpld1 and clusterin that improve hippocampal plasticity, neurogenesis and cognition, while old plasma carries factors including CCL11 and beta-2 microglobulin that impair them.
Regulatory history: Plasma is a licensed blood component with defined clinical indications in coagulation and plasma exchange. Infusion for ageing, memory loss or neurodegeneration is not an approved use. FDA published a consumer warning about clinics selling it on 19 February 2019.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Young Plasma Infusion at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Young Plasma Infusion in other countries
United Kingdom
ApprovedLicensed blood component; not licensed for ageing indications
Is Young Plasma Infusion legal in the United Kingdom?Australia
ApprovedLicensed blood component; not registered for ageing indications
Is Young Plasma Infusion legal in Australia?Canada
ApprovedLicensed blood component; not approved for ageing indications
Is Young Plasma Infusion legal in Canada?Frequently asked questions
Is Young Plasma Infusion legal in the United States?
Yes. Young Plasma Infusion is an approved medicine in the United States, classified as "Licensed blood component; infusion for ageing is an unapproved use". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: FDA consumer statement of 19 February 2019 advises caution about establishments selling young donor plasma infusions.
Can I buy Young Plasma Infusion in the United States?
Only with a prescription. Young Plasma Infusion is classified as "Licensed blood component; infusion for ageing is an unapproved use" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: FDA consumer statement of 19 February 2019 advises caution about establishments selling young donor plasma infusions.
Is Young Plasma Infusion FDA approved?
Yes. FDA status: Plasma is a licensed blood component with defined clinical indications in coagulation and plasma exchange. Infusion for ageing, memory loss or neurodegeneration is not an approved use. FDA published a consumer warning about clinics selling it on 19 February 2019.. Current US classification: "Licensed blood component; infusion for ageing is an unapproved use". On the evidence, 3 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Young Plasma Infusion live on its compound profile.
Young Plasma Infusion profileThis page is general information about the regulatory status of Young Plasma Infusion in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.